EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | March 15th, 2025

Here are the top stories from the last week:

Industry Updates

Senators Partner on Bipartisan Bill to Crack Down on PBM’s Abusive Pricing Practices
A new bipartisan bill targets pharmacy benefit managers (PBMs) to address abusive pricing practices, aiming to protect pharmacies and save costs. Learn more »

AAM Commends Q1/Q2 House Bill Reintroduction
According to the Association for Accessible Medicines, the bill on the floor will cut red tape, bring lower-cost medicines to patients faster, and save money. Learn more »

CVS Health to Open Smaller Format Stores
Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase. Learn more »

NIH Limits Grants for Vaccine Hesitancy Studies, Raising Question about Future of Research
Recently, the National Institutes of Health decided to limit grants for studies on vaccine hesitancy, which could significantly impact future research in the area. Learn more »

Integrating Vitamins & Supplements in Multiple Sclerosis Treatment
A recent study provided insights into the potential integration of vitamins and supplements into treatment regimens for multiple sclerosis to improve patient outcomes. Learn more »

Study Finds Elevated RSV Hospitalization Rates in Patients with Asthma, COPD
Adults with asthma or chronic obstructive pulmonary disease (COPD) have a heightened risk of RSV-related illnesses, leading to increased hospitalization rates. Learn more »

NHIA Applauds Bipartisan Bill to Improve Home Infusion Access in Medicare
A recent bipartisan bill drew acclaim from the National Home Infusion Association (NHIA), aiming to improve access to home infusion services for Medicare patients. Learn more »

New Study Shows that Pharmacies Can Help Combat Substance Abuse
A new study highlights the role of pharmacies in combating substance abuse through innovative partnerships that improve health outcomes. Learn more »

Drug Updates

FDA Approves Celltrion’s Xolair Biosimilar
Omyclo is used for the treatment of moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, immunoglobin E-mediated food allergy, and chronic spontaneous urticaria. Learn more »

Lupin Launches Generic Xarelto
Rivaroxaban tablets are used to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD). Learn more »

Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial
This article highlights a clinical trial where patients on cagrilintide/semaglutide treatment experienced significant weight loss, averaging 15.7 percent. Learn more »

Biocon Biologics, Civica Collaborate to Expand Insulin Aspart Access
Biocon Biologics will supply Insulin Aspart drug substance to Civica, who will use the drug substance to produce Insulin Aspart drug product. Learn more »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®